Cargando…

Vaccinia Virus-Based Reverse Genetics for Feline Coronaviruses

For decades, the genetic modification of coronavirus genomes and the generation of recombinant coronaviruses have been hampered mostly due to the extraordinary large size of the coronaviral genome. The very first reverse genetic system for feline coronaviruses (FCoVs) was established in the early 20...

Descripción completa

Detalles Bibliográficos
Autor principal: Tekes, Gergely
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122496/
http://dx.doi.org/10.1007/978-1-4939-3414-0_7
_version_ 1783515430445383680
author Tekes, Gergely
author_facet Tekes, Gergely
author_sort Tekes, Gergely
collection PubMed
description For decades, the genetic modification of coronavirus genomes and the generation of recombinant coronaviruses have been hampered mostly due to the extraordinary large size of the coronaviral genome. The very first reverse genetic system for feline coronaviruses (FCoVs) was established in the early 2000s; the respective approach exclusively enabled the manipulation of the 3′-third of the viral genome. Later on, vaccinia virus- and bacterial artificial chromosome (BAC)-based systems have been developed. Both systems have the advantage that the entire FCoV genome is amenable for mutagenesis. The main focus of this chapter is the vaccinia virus-based reverse genetic system for FCoVs. Here we present protocols for (1) the generation of a full-length cDNA clone, (2) the manipulation of the FCoV genome, and (3) the rescue of recombinant FCoVs.
format Online
Article
Text
id pubmed-7122496
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-71224962020-04-06 Vaccinia Virus-Based Reverse Genetics for Feline Coronaviruses Tekes, Gergely Animal Coronaviruses Article For decades, the genetic modification of coronavirus genomes and the generation of recombinant coronaviruses have been hampered mostly due to the extraordinary large size of the coronaviral genome. The very first reverse genetic system for feline coronaviruses (FCoVs) was established in the early 2000s; the respective approach exclusively enabled the manipulation of the 3′-third of the viral genome. Later on, vaccinia virus- and bacterial artificial chromosome (BAC)-based systems have been developed. Both systems have the advantage that the entire FCoV genome is amenable for mutagenesis. The main focus of this chapter is the vaccinia virus-based reverse genetic system for FCoVs. Here we present protocols for (1) the generation of a full-length cDNA clone, (2) the manipulation of the FCoV genome, and (3) the rescue of recombinant FCoVs. 2015-09-10 /pmc/articles/PMC7122496/ http://dx.doi.org/10.1007/978-1-4939-3414-0_7 Text en © Springer Science+Business Media New York 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Tekes, Gergely
Vaccinia Virus-Based Reverse Genetics for Feline Coronaviruses
title Vaccinia Virus-Based Reverse Genetics for Feline Coronaviruses
title_full Vaccinia Virus-Based Reverse Genetics for Feline Coronaviruses
title_fullStr Vaccinia Virus-Based Reverse Genetics for Feline Coronaviruses
title_full_unstemmed Vaccinia Virus-Based Reverse Genetics for Feline Coronaviruses
title_short Vaccinia Virus-Based Reverse Genetics for Feline Coronaviruses
title_sort vaccinia virus-based reverse genetics for feline coronaviruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122496/
http://dx.doi.org/10.1007/978-1-4939-3414-0_7
work_keys_str_mv AT tekesgergely vacciniavirusbasedreversegeneticsforfelinecoronaviruses